Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-12-26 Purchase |
2023-12-28 4:39 pm |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
10,857 | $9.2989 | $100,958 | 10,857 (Direct) |
View |
2020-09-17 Sale |
2020-09-18 4:06 pm |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
5,767 | $50.16 | $289,259 | 380,967 (Indirect Direct) |
View |
2020-09-14 Sale |
2020-09-16 6:35 pm |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
4,233 | $50.14 | $212,224 | 386,734 (Indirect Direct) |
View |
2020-07-07 Sale |
2020-07-09 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
5,000 | $50 | $250,000 | 390,967 (Indirect Direct) |
View |
2020-06-03 Sale |
2020-06-05 4:06 pm |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
5,000 | $50 | $250,000 | 394,879 (Indirect Direct) |
View |
2020-05-28 Sale |
2020-06-01 4:05 pm |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
5,000 | $50 | $250,000 | 401,475 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-01 Option Award |
2025-04-03 6:11 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
559 | $0 | 11,416 (Direct) |
View |
2024-06-10 Option Award |
2024-06-12 7:32 pm |
2025-06-10 2034-06-10 |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
20,594 | $0 | 20,594 (Direct) |
View |
2023-06-12 Option Award |
2023-06-14 7:30 pm |
2024-06-12 2033-06-12 |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
22,123 | $0 | 22,123 (Direct) |
View |
2023-03-03 Option Award |
2023-03-07 5:59 pm |
N/A 2033-03-03 |
Edgewise Therapeutics Inc. | EWTX | Fox Jonathan C Director |
43,731 | $0 | 43,731 (Direct) |
View |
2020-12-28 Gift |
2021-01-28 7:50 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
500 | $0 | 0 (Direct) |
View |
2021-01-26 Equity Swap |
2021-01-28 7:50 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
380,467 | $0 | 0 (Direct) |
View |
2020-06-29 Other |
2020-07-01 4:06 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
1,088 | $0 | 397,055 (Indirect) |
View |
2020-05-31 Option Award |
2020-06-05 4:06 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
444 | $41.57 | 394,879 (Direct) |
View |
2020-06-01 Gift |
2020-06-05 4:06 pm |
N/A N/A |
Eidos Therapeutics Inc. | EIDX | Fox Jonathan C See Remarks |
2,040 | $0 | 394,879 (Indirect) |
View |